StocksMedium•22 October 2026•
1 min read
De Tubize Shares Rise as UCB Upgrades Full-Year Financial Guidance
Key Facts
1De Tubize shares surged after Belgian pharmaceutical firm UCB raised its full-year financial guidance.
De Tubize shares surged after Belgian pharmaceutical firm UCB raised its full-year financial guidance. Investing.com reported that the upward revision followed stronger-than-expected performance within the company's pharmaceutical portfolio.
As the primary shareholder of UCB, De Tubize saw significant positive price action following the announcement on October 22, 2026. The revised outlook for annual earnings and revenue suggests continued growth for the Belgian drugmaker, directly impacting the valuation of its holding company.